Wilson MR, Azzabi Zouraq I, Chevrou-Severac H, Selby R, Kerrigan MC. Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK. Clinicoecon Outcomes Res. 2017 Oct 16;9:641-52. doi: 10.2147/CEOR.S135609
Eze IC, Foraster M, Schaffner E, Vienneau D, Heritier H, Rudzik F, Thiesse L, Pieren R, Imboden M, von Eckardstein A, Schindler C, Brink M, Cajochen C, Wunderli J, Roosli M, Probst-Hensch N. Long-term exposure to transportation noise and air pollution in relation to incident diabetes in the SAPALDIA study. Int J Epidemiol. 2017 Aug 1;46(4):1115-25. doi: 10.1093/ije/dyx020
Julvez J, Avella-Garcia C, Garcia-Esteban R, Basagana X, Sunyer J. Response to the comment: variable selection should be blinded to the outcome. Int J Epidemiol. 2017 Jun 1;46(3):1079-80. doi: 10.1093/ije/dyx049